Antibody targets and destroys cells implicated in systemic lupus erythmatosis

May 5, 2016, Journal of Clinical Investigation

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organ systems. Autoantibodies, which are produced by B cells, contribute to development of SLE. Recent studies have also shown that type 1 interferons (IFNs) and associated inflammatory molecules are highly expressed in serum from SLE patients. Specialized cells called plasmacytoid dendritic cells (pDCs) primarily produce type 1 IFNs and may represent a therapeutic target for SLE therapies.

In this issue of JCI Insight, research groups led by Ian Wicks of the University of Melbourne and Nicholas Wilson of CSL Limited developed an antibody (CSL362) directed against the surface molecule CD123 that targets and depletes pDCs and other cells implicated in SLE. CD123 was found on the surface of pDCs and basophils in blood from both healthy volunteers and SLE patients.

CSL362 depleted these populations in whole blood and reduced production of type 1 IFN and type 1 IFN-induced genes, while also preventing expansion of antibody-producing cells. Importantly, this antibody effectively depleted pDCs and basophils in non-human primates and reduced induction of type 1 IFN-associated genes in the peripheral blood cells of these animals.

Further studies will be required to determine if this antibody will benefit patients with SLE.

Explore further: Study reveals role for oxidized mitochondrial DNA in lupus

More information: Shereen Oon et al, A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus, JCI Insight (2016). DOI: 10.1172/jci.insight.86131

Related Stories

Study reveals role for oxidized mitochondrial DNA in lupus

April 18, 2016
Researchers at the Baylor Institute for Immunology Research have discovered that the neutrophils of systemic lupus erythematosus (SLE) patients release oxidized DNA from their mitochondria that can stimulate an unwanted immune ...

SLICC/ACR criteria don't ID severe internal disease in SCLE

April 27, 2016
(HealthDay)—Neither the American College of Rheumatology (ACR) nor the Systemic Lupus International Collaborating Clinics (SLICC) criteria distinguishes patients with subacute cutaneous lupus erythematosus (SCLE) with major ...

Identifying targets of autoantibodies

November 25, 2013
Patients with the autoimmune disease systemic lupus erythematosus (SLE) produce autoantibodies that target can cause damage to multiple organ systems. The host factors that are targeted by autoantibodies produced by SLE patients ...

Researchers find new clue in lupus autoantibody production

April 12, 2016
A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers ...

Vitamin D shows no impact on interferon response in SLE

July 10, 2015
(HealthDay)—For patients with systemic lupus erythematosus (SLE), vitamin D3 supplementation does not affect interferon (IFN) signature, according to a study published in the July issue of Arthritis & Rheumatology.

Pediatric discoid lupus carries significant progression risk

April 3, 2015
(HealthDay)—Pediatric discoid lupus erythematosus (DLE) carries a significant risk of progression to systemic lupus erythematosus (SLE), according to a review published in the April issue of the Journal of the American ...

Recommended for you

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Defense against joint degeneration

October 30, 2018
During cartilage development, chondrocytes secrete the extracellular matrix (ECM) and embed within the same environment. During progressive joint disease, such as osteoarthritis (OA), dysregulation of the process can lead ...

Becoming more sensitive to pain increases the risk of knee pain not going away

October 30, 2018
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers at Université de Montréal and its affiliated ...

Ground-breaking discovery finds new link between autoimmune diseases and a gut bacterium

October 29, 2018
Could microbes in our guts be sending out the wrong message? Queen's University Belfast researchers have, for the first time, found a specific microbe in the gut that pumps out protein molecules that mimic a human protein, ...

Research shows diet has little influence on precursor to gout

October 11, 2018
Dietary factors have a far smaller influence on urate levels (a precursor to gout) than previously envisaged, new University of Otago research reveals.

More doctor visits lead to less suicide attempts for fibromyalgia patients

September 19, 2018
Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.